Cargando…
Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of
While methimazole (MMI) is the first line treatment for hyperthyroidism, this medication is not devoid of adverse effects. In this article, we present a 70-year-old male who admitted the hospital with right lower extremity pain and rash. The patient was recently treated with MMI for hyperthyroidism....
Autores principales: | Qaisar, Huzaif, Hossain, Mohammad A., Akula, Monika, Cheng, Jennifer, Patel, Mayurkumar, Min, Zheng, Kuzyshyn, Halyna, Levitt, Michael, Coley, Shana M., Asif, Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135002/ https://www.ncbi.nlm.nih.gov/pubmed/30214651 http://dx.doi.org/10.14740/jocmr3530w |
Ejemplares similares
-
An Unusual Presentation of Pauci-Immune Necrotizing Glomerulonephritis
por: Talon, Andrew, et al.
Publicado: (2020) -
ANCA negative pauci-immune glomerulonephritis with systemic involvement
por: Sampathkumar, K., et al.
Publicado: (2010) -
ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012) -
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
por: Syed, Rafeel, et al.
Publicado: (2015) -
Pauci-Immune Crescentic Glomerulonephritis in Connective Tissue Disease
por: Yeturi, Supraja, et al.
Publicado: (2016)